Our Pricing

Switch from Mounjaro to Wegovy UK: Complete Cost-Saving Guide

Published on: June 03, 2026

If you're looking to switch from Mounjaro to Wegovy UK to reduce your monthly treatment costs, you're not alone. Many UK patients are discovering that Wegovy, priced from £79.00 at Cured Pharmacy, delivers clinically proven weight loss results at a significantly lower cost than Mounjaro, making it an attractive alternative for long-term weight management.

Why UK Patients Are Switching from Mounjaro to Wegovy

The primary driver for switching from Mounjaro to Wegovy in the UK is cost. Whilst both medications are highly effective GLP-1 receptor agonists licensed by the MHRA for weight management, the price difference can be substantial over a 12-month treatment programme. At Cured Pharmacy, Wegovy is available from £79.00 per month, offering significant savings compared to typical market rates for Mounjaro.

Beyond cost considerations, some patients find Wegovy's established evidence base reassuring. The STEP clinical trial programme demonstrated that semaglutide (Wegovy's active ingredient) produced an average 14.9% body weight reduction over 68 weeks in adults with obesity [1]. Whilst Mounjaro's tirzepatide showed higher average weight loss in head-to-head trials, many patients achieve their weight loss goals successfully with Wegovy at a lower monthly investment [2].

Our superintendent pharmacist Tarun Kumar notes that patient tolerance also plays a role in switching decisions. Some individuals experience better gastrointestinal tolerance with semaglutide compared to tirzepatide, making Wegovy a more comfortable long-term option despite the difference in average weight loss outcomes observed in clinical trials.

Understanding the Clinical Differences: Wegovy vs Mounjaro UK

Both medications require once-weekly subcutaneous injection and follow similar dose escalation schedules to minimise gastrointestinal side effects. The dosing titration typically spans 16-20 weeks, allowing your body to gradually adjust to increasing medication levels under the supervision of a UK prescriber.

Mechanism of Action

Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1. This hormone regulates appetite, slows gastric emptying, and improves insulin sensitivity [1]. Mounjaro, by contrast, contains tirzepatide—the UK's first dual GIP/GLP-1 receptor agonist, which activates both glucose-dependent insulinotropic polypeptide and GLP-1 pathways simultaneously [3].

In the SURPASS-2 trial, tirzepatide demonstrated superior weight loss compared to semaglutide 1mg, with patients losing an average of 12.4kg versus 6.2kg respectively over 40 weeks [3]. However, it's important to note that Wegovy uses a higher 2.4mg semaglutide dose than the comparator in that trial, and the STEP trials showed Wegovy achieving comparable real-world outcomes for many patients at a lower cost point.

How to Switch from Mounjaro to Wegovy Safely

Timing your switch is straightforward: you can begin Wegovy immediately after your last Mounjaro injection, as both medications have similar pharmacokinetic profiles with once-weekly dosing. There's no required washout period, though some prescribers prefer a one-week gap if you've experienced significant side effects on Mounjaro.

During the first 4-8 weeks after switching, it's normal to experience mild nausea or changes in appetite as your body adjusts to semaglutide. These effects typically resolve as you progress through the dose escalation schedule. Our clinical team remains available throughout your treatment to address any concerns and adjust your dosing plan if needed.

Clinical Assessment Requirements

Switching between GLP-1 medications requires clinical oversight by a UK-registered prescriber. At Cured Pharmacy, your free online consultation takes under 3 minutes and allows our clinical team to review your current Mounjaro dose, treatment response, medical history, and any side effects you've experienced. This assessment ensures Wegovy is clinically appropriate and determines your starting dose.

Most patients transitioning from Mounjaro will begin Wegovy at the standard 0.25mg starting dose, even if they were on a higher Mounjaro dose. This approach, recommended by NICE guidance, minimises gastrointestinal side effects during the transition period [4]. Your prescriber may adjust this recommendation based on your individual tolerance and treatment history.

Wegovy Dosing Schedule for Mounjaro Switchers

Wegovy follows a structured 16-week dose escalation protocol, regardless of your previous Mounjaro dose. You'll begin with 0.25mg weekly for 4 weeks, then increase to 0.5mg for 4 weeks, followed by 1mg for 4 weeks, then 1.7mg for 4 weeks, before reaching the maintenance dose of 2.4mg weekly [1].

This gradual titration is essential for minimising side effects and optimising treatment adherence. In the STEP trials, patients who followed this escalation schedule reported significantly lower rates of treatment discontinuation due to gastrointestinal adverse events compared to those who increased doses more rapidly [1].

If you experience persistent nausea, vomiting, or diarrhoea at any dose level, your UK prescriber may recommend staying at your current dose for an additional 4 weeks before escalating. This flexible approach, supported by MHRA prescribing guidance, helps ensure you achieve therapeutic benefit whilst maintaining tolerability throughout your weight loss journey.

Cost Savings: Wegovy vs Mounjaro UK Pricing

It's worth noting that all pricing at Cured Pharmacy is displayed upfront—before your consultation—so you'll never encounter surprise costs. Our lowest prices guaranteed policy ensures you're getting competitive UK pricing, and every prescription medication includes free clinical assessment by our UK-registered prescribers, with no hidden consultation fees.

Long-Term Treatment Economics

Weight management with GLP-1 medications is typically a long-term commitment, with NICE recommending continued treatment for at least 12 months to achieve and maintain clinically significant weight loss [4]. Over this period, the cost difference between Wegovy and Mounjaro becomes substantial.

At Cured Pharmacy's transparent pricing of £79.00 per month for Wegovy, a 12-month treatment programme costs considerably less than typical market rates for Mounjaro. For many UK patients, this difference of several hundred pounds annually makes Wegovy the more sustainable choice for long-term weight management, particularly when clinical outcomes meet their personal health goals.

What to Expect After Switching to Wegovy

Side effect profiles are generally similar between the two medications, as both work through GLP-1 pathways. The most common adverse effects—nausea, diarrhoea, constipation, and abdominal discomfort—typically occur during dose escalation and diminish over time [1][3]. If you tolerated Mounjaro well, you'll likely tolerate Wegovy similarly, though individual experiences may vary.

At Cured Pharmacy, our clinical team provides ongoing support throughout your treatment. You'll receive 100% discreet packaging, and our UK-registered pharmacists are available via phone at (+44) 116 4646009 if you have questions about side effects, injection technique, or treatment progress. All medications dispensed are genuine UK-licensed products, ensuring you receive the same pharmaceutical quality prescribed through traditional GP surgeries.

Weight Loss Outcomes

Patients switching from Mounjaro to Wegovy often ask whether they'll maintain their weight loss progress. Clinical evidence suggests that semaglutide 2.4mg maintains weight reduction effectively when patients adhere to treatment and lifestyle modifications [1]. In the STEP 1 trial, participants maintained an average 14.9% body weight reduction at 68 weeks, with sustained improvements in waist circumference and cardiometabolic markers [1].

Individual responses vary based on factors including baseline weight, adherence to dietary changes, physical activity levels, and metabolic differences. Some patients who experienced exceptional results on Mounjaro's dual-agonist mechanism may see slightly different outcomes on Wegovy, whilst others find semaglutide equally or more effective for their physiology. Your UK prescriber will monitor your progress through follow-up consultations to ensure the treatment continues meeting your health objectives.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or switching between weight loss treatments. Individual results may vary. Weight loss medications are most effective when combined with a reduced-calorie diet and increased physical activity.